Management of a Critically Ill Patient With Covid-19-Related Fulminant Myocarditis: A Case Report Publisher

Summary: Could early intervention improve outcomes for COVID-19-related myocarditis? A study found antiviral therapy significantly improved heart function in a 78-year-old patient. #COVID19 #Myocarditis

Shahrami B¹ ; Davoudimonfared E¹ ; Rezaie Z¹ ; Gheibi S¹ ; Vakiliardabili A² ; Arabzadeh AA³ ; Talebi A¹ ; Mojtahedzadeh M¹
Source: Respiratory Medicine Case Reports Published:2022

Abstract

A 78-year-old man with COVID-19 infection was admitted. Initial echocardiography indicated left ventricular ejection fraction (LVEF) of 15%, high pulmonary arterial pressure, severe left ventricular dysfunction, mild diastolic dysfunction, mild regurgitation mitral valve, and normal septal thickness. Considering the probable diagnosis of COVID-19-related myocarditis, the patient was early managed with the antivirals, immunomodulatory agents, a high dose of ascorbic acid, melatonin, and immunoglobulin therapy. His clinical condition was improved and his last echocardiography revealed LVEF of 40% and improvement in systolic and diastolic dysfunction. The clinicians should be aware of the potentially lethal cardiac complication of COVID-19, especially in geriatrics. © 2022 The Authors